Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PHENPROCOUMON for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where PHENPROCOUMON was used for Pulmonary embolism.

Most Reported Side Effects for PHENPROCOUMON

Side Effect Reports % Deaths Hosp.
Anaemia 242 17.5% 1 230
General physical health deterioration 172 12.4% 4 171
Haematochezia 162 11.7% 5 162
Dyspnoea 140 10.1% 6 130
Gastrointestinal haemorrhage 122 8.8% 29 68
Overdose 109 7.9% 13 96
Dizziness 108 7.8% 11 87
Haematoma 108 7.8% 24 76
Product prescribing error 104 7.5% 4 101
Fall 92 6.6% 5 87
International normalised ratio increased 81 5.8% 4 57
Product monitoring error 76 5.5% 0 76
Haemorrhage 67 4.8% 5 47
Atrial fibrillation 66 4.8% 2 63
Nausea 63 4.5% 2 61

Other Indications for PHENPROCOUMON

Product used for unknown indication (707) Atrial fibrillation (182) Anticoagulant therapy (90) Thrombosis prophylaxis (28) Cardiac disorder (24) Deep vein thrombosis (11) Heart valve replacement (11) Mitral valve replacement (11) Factor v deficiency (10) Suicide attempt (10)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) APIXABAN (5,234) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284)

Related Pages

PHENPROCOUMON Full Profile All Pulmonary embolism Drugs PHENPROCOUMON Demographics PHENPROCOUMON Timeline